Scholar Rock Holding Corp (SRRK) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Scholar Rock Holding Corp ranks 7 of 7 in its cohort on the Closelook composite (26/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
SRRK Scholar Rock Holding Corp 26 47 0 info 24.5%
BION.SW BB Biotech AG 74 74 96 81 info 8.2%
ARGX.BR Argen-X 65 79 75 28 ok 5.8%
ARGX argenx NV ADR 64 79 74 27 ok 7.7%
ONC BeiGene, Ltd. 63 75 63 32 ok 8.9%
REGN Regeneron Pharmaceuticals Inc 60 64 71 51 bull 8.1%
UCB.BR UCB SA 60 17 70 58 warn 27.8%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Scholar Rock Holding Corp's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: BB Biotech AG (BION.SW), Argen-X (ARGX.BR), argenx NV ADR (ARGX), BeiGene, Ltd. (ONC), Regeneron Pharmaceuticals Inc (REGN), UCB SA (UCB.BR).

How does SRRK score against its peers?

Scholar Rock Holding Corp's composite reads 26/100, ranking 7 of 7 in its cohort as of 2026-09-18; the cohort's highest composite is BB Biotech AG at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.